Oral controlled release technology for peptides: Status and future prospects

Pharmaceutical Research

Volumn 13, Issue 12, 1996, Pages 1760-1764

  Fix, Joseph A ^a  

^a ALZA CORPORATION   (United States)

Author keywords

Absorption enhancers; Chemical stability; Enzymatic degradation; Oral drug delivery; Peptide absorption

Indexed keywords

ACYLCARNITINE; CALCITONIN; CYCLOSPORIN; GLUCOSE; GLYCOCHOLATE SODIUM; INSULIN; PEPTIDES AND PROTEINS; PROTEINASE INHIBITOR; SALICYLATE SODIUM;

CONTROLLED DRUG RELEASE; DEGRADATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; GASTROINTESTINAL ABSORPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FORECASTING; HUMANS; INTESTINAL ABSORPTION; PEPTIDES;

EID: 0030460690     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016008419367     Document Type: Review

References (33)

1. M. J. Humphrey and P. S. Ringrose. Peptide and related drugs: A review of their absorption, metabolism, and excretion. Drug Metab. Reviews 17:283-310 (1986).
2. V. H. L. Lee, A. Yamamoto, and U. B. Kompella. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Systems 8:91-192 (1991).
3. H. P. Merkle. New aspects of pharmaceutical dosage forms for controlled drug delivery of peptides and proteins. Eur. J. Pharm. Sci. 2:19-21 (1994).
4. C. Lehr. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Systems 11:119-160 (1994).
5. J. M. Sarciaux, L. Acar, and P. A. Sado. Using microemulsion formulations for oral drug delivery of therapeutic peptides. Int. J. Pharm. 120:127-136 (1995).
6. M. J. Humphrey. The oral bioavailability of peptides and related drugs. In S. S. Davis, L. Illum, and E. Thomlinson (eds.), Delivery Systems for Peptide Drugs, pp. 139-151, 1986, Plenum Press, New York.
7. V. H. L. Lee. Enzymatic barriers to peptide and protein absorption. Crit. Rev. Ther. Drug Carrier Systems 5:69-97 (1988).
8. S. Yoshioka, L. Caldwell, and T. Higuchi. Enhanced rectal bioavailability of polypeptides using sodium 5-methoxysalicylate as an absorption promoter. J. Pharm. Sci. 71:593-597 (1982).
9. J. C. Scott-Moncrieff, Z. Shao, and A. K. Mitra. Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs. J. Pharm. Sci. 83:1465-1469 (1994).
10. M. J. Cho, J. F. Scieszka, and P. S. Burton. Citric acid as an adjuvant for transepithelial transport. Int. J. Pharm. 52:79-81 (1989).
11. S. Muranishi, Y. Tokunaga, K. Taniguchi, and H. Sezaki. Potential absorption of heparin from the small intestine and the large intestine in the presence of monoolein mixed micelles. Chem. Pharm. Bull. 25:1159-1163 (1977).
12. J. A. Fix, K. Engle, P. A. Porter, P. S. Leppert, S. J. Selk, C. R. Gardner, and J. Alexander. Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. Am. J. Physiol. 251:G332-G340 (1986).
13. Z. Shao, Y. Li, R. Krishnamoorthy, T. Chermak, and A. K. Mitra. Differential effects of anionic, cationic, nonionic, and physiologic surfactant on the dissociation, chymotrypsin degradation, and enterai absorption of insulin hexamers. Pharm. Res. 10:243-250 (1993).
14. P. P. Constantinides, J. Scalart, C. Lancaster, J. Marcello, G. Marks, H. Ellens, and P. L. Smith. Water-in-oil microemulsions containing medium-chain glyceride: Formulation and absorption evaluation in rat. Proc. Int. Symp. Control. Release Bioactive Mater. 20:184-185 (1993).
15. E. Bjork, U. Isaksson, P. Edman, and P. Artursson. Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of tight junctions. J. Drug Targeting 2:501-507 (1995).
16. J. A. Fix. Strategies for delivery of peptides utilizing absorption enhancing agents. Meeting Abstract, Conf. on Formulations and Drug Delivery, ACS, Boston (1995).
17. M. Mesiha and M. Sidhom. Increased oral absorption enhancement of insulin by medium viscosity hydroxypropyl cellulose. Int. J. Pharm. 114:137-140 (1995).
18. E. A. Hosny, N. M. Khan Ghilzai, and A. H. Al-Dhawalie. Effective intestinal absorption of insulin in diabetic rats using enteric coated capsules containing sodium salicylate. Drug Devel. Ind. Pharm. 21:1583-1589 (1995).
19. G. Fricker and J. Drewe. Enteral absorption of octreotide: Modulation of intestinal permeability by distinct carbohydrates. J. Pharmacol. Exp. Ther. 274:826-832 (1995).
20. J. P. F. Bai and G. L. Amidon. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm. Res. 9:969-978 (1992).
21. P. Buhlmayer, A. Caselli, W. Fuhrer, R. Goschkler, V. Rasetti, H. Rueger, J. L. Stanton, L. Criscione, and J. M. Wood. Synthesis and biological activity of some transition state inhibitors of human renin. J. Med. Chem. 31:1839 (1988).
22. A. Yamamato, T. Taniguchi, K. Rikyuu, T. Tsuji, T. Fujita, M. Murakami, and J. Muranishi. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 11:1496-1500 (1994).
23. V. H. L. Lee. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Controlled Rel. 13:213-223 (1991).
24. S. Fuiji, T. Yokohama, K. Ikegaya, F. Sato, and N. Yohoo. Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs. J. Pharm. Pharmacol. 37:545-549 (1985).
25. A. T. Florence, A. M. Hillery, N. Hussain, and P. U. Jani. Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate. J. Controlled Rel. 36:36-46 (1995).
26. P. P. Constantinides, C. M. Lancaster, J. Marcello, D. C. Chiossone, D. Orner, I. Hildalgo, P. L. Smith, A. B. Sarkahian, S. H. Yiv, and A. J. Owen. Enhanced intestinal absorption of an RGD peptide from water-in-oil microemulsions of different composition and particle size. J. Controlled Rel. 34:109-116 (1995).
27. S. Rao and W. A. Ritschel. Colonic drug delivery of small peptides. S.T.P. Pharma Sciences 5:19-29 (1995).
28. H. Brondsted and J. Kopecek. Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharm. Res. 9:1540-1545 (1992).
29. A. Rubinstein, R. Radai, M. Ezra, S. Pathak, and J. S. Rokem. In vitro evaluation of calcium pectinate: a potential colonic-specific drug delivery carrier. Pharm. Res. 10:258-263 (1993).
30. J. P. F. Bai and L. L. Chang. Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium. Pharm. Res. 12:1171-1175 (1995).
31. Y. Taki, T. Sakane, T. Nadai, H. Sezaki, G. L. Amidon, P. Langguth, and S. Yamashita. Gastrointestinal absorption of peptide drug: Quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine. J. Pharmacol. Exp. Ther. 274:373-377 (1995).
32. V. H. L. Lee, S. Dodda-Kashi, G. M. Grass, and W. Rubas. Oral route of peptide and protein drug delivery. In V. H. L. Lee (ed.), Protein and Peptide Drug Delivery, pp. 691-738, 1991, Dekker, New York.
33. L. Hovgaard, E. J. Mack, and S. W. Kim. Insulin stabilization and GI absorption. J. Controlled Rel. 19:99-108 (1992).